Clinical Trial

CyberKnife Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma Patients With Decompensated Cirrhosis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 27, 2023 (before its estimated August 30, 2023 completion). Its status may not reflect the trial's current state.
Summary
The aim of our research is to evaluate the curative effect and safety of CyberKnife stereotactic body radiation therapy in treating small hepatocellular carcinoma (HCC) patients with decompensated cirrhosis.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-08-11; most recent amendment 2023-06-24.
Trial Details
NCT Number NCT04512833
Lead Sponsor Beijing 302 Hospital
Conditions Hepatocellular Carcinoma
Enrollment 60 participants
Start Date 2020-08-12
Primary Completion 2023-08-30 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2023-06-27